Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Safety, Tolerability, and Pharmacodynamics of REDGEM-S-DNA in Healthy Adults
TCTR20251007008Phase 1Not yet recruiting
- Sponsor
- REDGEM MOLECULE
- Start
- Feb 2026
- Countries
- 1
01
Overview
Phase 1, single-arm trial, sponsored by REDGEM MOLECULE. Planned start Feb 2026; status: not yet recruiting.
Beyond the preview
Go deeper on TCTR20251007008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251007008.